Turn menstrual blood into medical breakthroughs.
Join us in solving conditions impacting billions of people with the power of period blood. Explore some of the conditions we're tackling below.
A pad with a purpose.
Introducing the Q-Pad, the first and only FDA-cleared diagnostic menstrual pad.
We believe all people who menstruate should have the choice to a non-invasive and needle-free way of managing their health. That's why we've crafted the Q-Pad to be conveniently and seamlessly used during menstruation, providing valuable health insights with ease.
Partner with Qvin
THE PROBLEM
Close the women’s health gap:
A $1 trillion opportunity to improve lives and economies worldwide
Source: McKinsey
THE SOLUTION
Qvin’s research shows menstrual blood reliably reveals multiple biomarkers, enabling noninvasive disease diagnosis and monitoring
HARNESSING THE POWER OF THE PERIOD
Within period blood, the untapped opportunity of non-invasive health information awaits
Over 70% of health decisions are made from lab work. Menstrual blood can reveal biomarkers that can replace existing sample collection methods, such invasive biopsies used for endometrial sampling, needles for blood collection, and speculum driven exams for e.g. PAP smears.
Rationale
Menstrual blood is an underutilized and biologically rich fluid with enormous potential to advance research and diagnostics in both gynecological and systemic health. It contains endometrial cells, immune components, hormones, and protein biomarkers reflective of the uterine and systemic environment. Studies show menstrual effluent can mirror venous blood biomarker profiles, supporting its use in monitoring metabolic and hormonal conditions [1]. It also contains unique cytokine and tissue-specific markers useful for detecting reproductive disorders such as endometriosis and adenomyosis [2][3]. By leveraging this monthly, non-invasive sample, we can democratize access to diagnostics and transform the way health is monitored and managed [4].
Q-Pad
The Q-Pad is a novel, patented collection device developed by Qvin that passively collects menstrual blood, specifically for health testing, using an embedded Dried Menstrual Sample strip. This simple, non-disruptive design enables individuals to contribute valuable biological samples from home. Validated research has shown strong correlation between biomarkers in menstrual blood collected via the Q-Pad and those in traditional venous draws—including HbA1c (r = 0.96) and key hormones like TSH and AMH (r > 0.9) [1][5]. The Q-Pad has already enabled the first-ever FDA-cleared menstrual blood diagnostic for diabetes, signaling a paradigm shift in women’s health diagnostics through accessible, needle-free testing [5].
Research
[1] Clinical Validation of Menstrual Blood for the Detection of Hemoglobin A1c and Other Blood-Based Biomarkers, Naseri S et al., Clinical Chemistry, 2023.
[2] Identification of Inflammatory and Regulatory Cytokines in Menstrual Effluent as Biomarkers of Endometriosis, Symons LK et al., Reproductive Sciences, 2018.
[3] Proteomic Analysis of Menstrual Effluent Identifies Biomarker Candidates for Endometriosis, Chen JC et al., Scientific Reports, 2022.
[4] Menstrual Blood Contains Cytokine Signatures Reflective of Uterine Immune Environment, van der Veen DR et al., eBioMedicine, 2023.
[5] Validation of a Menstrual Blood Collection Device for Glycemic Biomarker Analysis: A Non-Invasive Diagnostic Approach, Naseri S et al., Clinical Chemistry, 2023.
JOIN US
Transform the future of health
through menstrual blood research.
Join us in shaping the next generation of diagnostics and women's health.
Funding
If you represent a diagnostic platform, healthcare organization, or country-level agency and would like to work with us, please fill out this form and we will get back to you.
Research
If you are a scientist, foundation, or non-profit interested in collaborating on studies or supporting our innovation, please fill out the form and we will get back to you.